The online version of this article (doi:10.1186/1476-4598-11-7) contains supplementary material, which is available to authorized users.
SM prepared the manuscript. SS assisted in the preparation and RD edited and modified this review article. All authors read and approved the final manuscript.
The Wnt signaling pathway is involved in a wide range of embryonic patterning events and maintenance of homeostasis in adult tissues. The pathological role of the Wnt pathway has emerged from studies showing a high frequency of specific human cancers associated with mutations that constitutively activate the transcriptional response of these pathways. Constitutive activation of the Wnt signaling pathway is a common feature of solid tumors and contributes to tumor development, progression and metastasis in various cancers. In this review, the Wnt pathway will be covered from the perspective of urological cancers with emphasis placed on the recent published literature. Regulation of the Wnt signaling pathway by microRNAs (miRNA), small RNA sequences that modify gene expression profiles will also be discussed. An improved understanding of the basic genetics and biology of Wnt signaling pathway will provide insights into the development of novel chemopreventive and therapeutic strategies for urological cancers.
Harland RM: Developmental biology. A twist on embryonic signalling. Nature. 2001, 410: 423-424. PubMed
Zecca M, Basler K, Struhl G: Sequential organizing activities of engrailed, hedgehog and decapentaplegic in the Drosophila wing. Development. 1995, 121: 2265-2278. PubMed
Polakis P: Wnt signaling and cancer Genes Dev. 2000, 14: 1837-1851. PubMed
Bray S: A Notch affair Cell. 1998, 93: 499-503. PubMed
Itasaki N, Hoppler S: Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev Dyn. 2010, 239: (1):16-33. PubMed
Moon RT: Wnt/beta-catenin pathway. Sci STKE. 2005, 2005: (271):cm1- PubMed
Bradbury JM, Niemeyer CC, Dale TC, Edwards PA: Alterations of the growth characteristics of the fibroblast cell line C3H 10 T1/2 by members of the Wnt gene family. Oncogene. 1994, 9: 2597-2603. PubMed
Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J: Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ. 1997, 8: 1349-1358. PubMed
Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M: The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clin Cancer Res. 2003, 9: 2121-2132. PubMed
Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA: Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 2009, 69: 4674-4681. PubMedCentralPubMedCrossRef
Furge KA, Chen J, Koeman J, Swiatek P, Dykema K, Lucin K, Kahnoski R, Yang XJ, Teh BT: Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res. 2007, 67: 3171-3176. PubMedCrossRef
Beck I, Weinmann R, Caro J: Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood. 1993, 82: 704-711. PubMed
Chen F, Kishida T, Duh FM, Renbaum P, Orcutt ML, Schmidt L, Zbar B: Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res. 1995, 55: 4804-4807. PubMed
Zimmer M, Doucette D, Siddiqui N, Iliopoulos O: Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors. Mol Cancer Res. 2004, 2: 89-95. PubMed
Choi H, Chun YS, Kim TY, Park JW: HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin. Cancer Res. 2010, 70: (24):10101-10111. PubMed
Katoh M: WNT/PCP signaling pathway and human cancer (review). Oncol Rep. 2005, 14: 1583-1588. PubMed
Dennis S, Aikawa M, Szeto W: d'Amore PA, Papkoff J: A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates wnt-1 signaling. J Cell Sci. 1999, 112: (Pt 21):3815-3820.
Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O: Methylation-associated silencing of SFRP1 in renal cell carcinoma. Oncol Rep. 2008, 20: 1257-1263. PubMed
Giles RH, van Es JH, Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003, 1653: 1-24. PubMed
Battagli C, Uzzo RG, Dulaimi E: Ibanez de Caceres I, Krassenstein R, Al-Saleem T, Greenberg RE, Cairns P: Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Res. 2003, 63: 8695-8699. PubMed
Kawakami K, Yamamura S, Hirata H, Ueno K, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R: Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer. Int J Cancer. 2011, 128: (3):541-550. PubMedCentralPubMedCrossRef
Yee DS, Tang Y, Li X, Liu Z, Guo Y, Ghaffar S, McQueen P, Atreya D, Xie J, Simoneau AR: The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Mol Cancer. 2010, 9: 162- PubMedCentralPubMedCrossRef
Li Y, Kong D, Wang Z, Ahmad A, Bao B, Padhye S, Sarkar FH: Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells. Cancer Prev Res (Phila). 2011, 4: (9):1495-1506.
Thudi NK, Martin CK, Murahari S, Shu ST, Lanigan LG, Werbeck JL, Keller ET, McCauley LK, Pinzone JJ, Rosol TJ: Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. Prostate. 2011, 71: (6):615-625. PubMedCentralPubMedCrossRef
Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R: Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res. 2006, 12: 2109-2116. PubMedCrossRef
Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A: No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Int J Oncol. 2002, 20: 905-911. PubMed
Kastritis E, Murray S, Kyriakou F, Horti M, Tamvakis N, Kavantzas N, Patsouris ES, Noni A, Legaki S, Dimopoulos MA, Bamias A: Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication. Int J Cancer. 2009, 124: 103-108. PubMedCrossRef
Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M: Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res. 2006, 12: 383-391. PubMedCrossRef
Tarapore RS, Siddiqui IA, Mukhtar H: Modulation of Wnt/beta-catenin signaling pathway by bioactive food components. Carcinogenesis. 2012,
- Wnt signaling pathways in urological cancers: past decades and still growing
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II